Skip to main content
logo
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
57.72
-1.65 (-2.78%)
At close: Aug 28, 2026, 4:00 PM EDT
57.18
-0.54 (-0.94%)
Pre-market: Aug 31, 2026, 7:00 AM EDT

CRISPR Therapeutics AG Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
13.393.5137.31371.211.2914.96
Revenue Growth
-64.80%-90.59%-89.95%30885.48%-99.87%127154.94%
Gross Profit
-461.8-494.78-393.59-146.38-570.7473.22
Operating Income
-531.87-568.32-466.57-222.54-673.16373.53
Net Income
-451.14-581.6-366.25-153.61-650.18377.66
Earnings Per Share
-4.76-6.47-4.34-1.94-8.364.70
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Collaboration
--353700.44913.08
Grant
2.393.512.311.210.761.88
Revenue (Total)
13.393.5137.31371.211.2914.96

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,3641,9761,9041,6961,8682,379
Total Debt
783.75206.75223.69238.63244.02225.03
Net Cash (Debt)
1,5811,7691,6801,4571,6242,154
Net Cash Growth
4.97%5.29%15.31%-10.30%-24.59%32.24%
Net Cash Per Share
16.6719.6719.9218.3920.8926.79

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-369.58-345.01-142.77-260.38-495.74538.97
Capital Expenditures
-1.74-0.91-1.9-9.47-37.19-81.71
Free Cash Flow
-371.33-345.93-144.68-269.85-532.93457.27
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----39.43%-51.72%
Operating Margin
-3971.53%-16191.40%-1250.38%-59.95%-56190.40%40.82%
Pretax Margin
-3346.08%-16466.24%-971.93%-40.60%-54298.83%41.48%
Profit Margin
-3368.72%-16569.77%-981.54%-41.38%-54271.70%41.28%
FCF Margin
-2772.74%-9855.50%-387.72%-72.69%-44484.89%49.98%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----15.36
P/FCF Ratio
-----12.68
PS Ratio
416.751423.8090.0313.402656.646.34